retatrutide phase 2 type 2 diabetes trial is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 Retatrutide Phase 2: Type 2

1,200,000+ Your weight isn't a willpower problem

The potential benefits of semaglutide/pyridoxine blend: Combining vitamin B6 (pyridoxine) with semaglutide may offer several potential benefits

Medication: What's the Difference Food-based GLP-1 stimulation is modest and temporaryyour body releases small amounts of the hormone that return to baseline within hours of digestion

Why Early Adoption Requires More Than Prescription Counts Traditional launch tracking often relies on claims data that becomes available months after launch

In the obesity-focused ACHIEVE-4 trial, participants without diabetes lost up to 10.1% of body weight at the same timepoint

Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor